We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use an N-of-1 study to evaluate your digital health product.
Using an ecological momentary assessment to evaluate your digital health product.
Data on the real-world efficacy of the COVID-19 vaccines.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
How to use a case-control study to evaluate your digital health product.
As students prepare for freshers’ week, new research has found that nearly half of students worry they would be judged if they admitted to feeling lonely.
Providing vital research into COVID-19 immunity and vaccine effectiveness nationally.
How to use an ethnographic study to evaluate your digital health product.
How to use a micro-randomised trial to evaluate your digital health product.
Helping public health practitioners conducting evaluations – using outcome evaluations to find out if an intervention works.
How to use a behaviour change techniques review to evaluate your digital health product.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
How to use A/B testing to evaluate your digital health product.
UKHSA and ONS have today published the latest data from the Winter Coronavirus (COVID-19) Infection Study, known as the Winter CIS.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
How to use routinely collected data to evaluate your digital health product.
How to use a feasibility study when planning the evaluation of your digital health product.
An outline of the delivery patterns that are outside of standard delivery.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).